WINTEAM PHARMA
WINTEAM PHARMA operates in Diversified Metals & Mining.
WINTEAM PHARMA (WSG) - Total Liabilities
Latest total liabilities as of December 2023: €13.13 Billion EUR
Based on the latest financial reports, WINTEAM PHARMA (WSG) has total liabilities worth €13.13 Billion EUR as of December 2023.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
WINTEAM PHARMA - Total Liabilities Trend (2016–2023)
This chart illustrates how WINTEAM PHARMA's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
WINTEAM PHARMA Competitors by Total Liabilities
The table below lists competitors of WINTEAM PHARMA ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
CD Private Equity Fund I
AU:CD1
|
Australia | AU$633.01K |
|
Camrova Resources Inc
PINK:BAJFF
|
USA | $1.30 Million |
|
Afine Investments Ltd
JSE:ANI
|
South Africa | ZAC110.51 Million |
|
Vianet Group Plc
LSE:VNET
|
UK | GBX6.87 Million |
|
GRUPO FAMSA-A
MU:4FP
|
Germany | €25.93 Billion |
Liability Composition Analysis (2016–2023)
This chart breaks down WINTEAM PHARMA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.12 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.62 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.35 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how WINTEAM PHARMA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for WINTEAM PHARMA (2016–2023)
The table below shows the annual total liabilities of WINTEAM PHARMA from 2016 to 2023.
| Year | Total Liabilities | Change |
|---|---|---|
| 2023-12-31 | €13.13 Billion | +3.49% |
| 2022-12-31 | €12.69 Billion | -7.70% |
| 2021-12-31 | €13.75 Billion | +12.76% |
| 2020-12-31 | €12.19 Billion | -9.17% |
| 2019-12-31 | €13.42 Billion | +5.06% |
| 2018-12-31 | €12.78 Billion | +15.42% |
| 2017-12-31 | €11.07 Billion | +33.68% |
| 2016-12-31 | €8.28 Billion | -- |